Trial Profile
Everolimus-eluting bioresorbable vascular scaffolds in patients presenting with ST-segment elevation myocardial infarction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 11 Nov 2015 New trial record